Price $13.39 |
Market Cap
290.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
569.3
|
P/B
1.9
|
P/S
1.13
|
Dividend %
-
|
|
P/CF
7.0
|
P/FCF
17.0
|
Op. Cash Flow
19.5K
|
FCF
0.7
|
|
Op. Margin
1.70%
|
Net Margin
0.10%
|
ROE
0.30%
|
ROI
-8.90%
|
|
ROA
0.10%
|
EPS Growth
101.50%
|
Current Ratio
1.9
|
Debt/Equity
37.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
